Federal grants to Friends Research Institute, Inc
Friends Research Institute, Inc in Baltimore, Maryland received $38.1 million in federal grants from fiscal 2021 to 2025, across 23 awards. Its largest program was Drug Use and Addiction Research Programs, with $35.8 million. In fiscal 2025 it was awarded $7.7 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$38.1 million
- Awards23
- Awarded in FY 2025$7.7 million
- Largest award$7.3 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 6 | $5.5 million |
| FY 2022 | 9 | $9.8 million |
| FY 2023 | 12 | $9.3 million |
| FY 2024 | 10 | $5.8 million |
| FY 2025 | 11 | $7.7 million |
Programs that fund Friends Research Institute, Inc
| Program | Awards | Amount |
|---|---|---|
| Drug Use and Addiction Research Programs | 19 | $35.8 million |
| Research on Healthcare Costs, Quality and Outcomes | 1 | $1.1 million |
| Nursing Research | 1 | $783,321 |
| Mental Health Research Grants | 1 | $372,467 |
| Trans-NIH Research Support | 1 | $100,000 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 23 | $38.1 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| A comparative effectiveness trial of extended release naltrexone versus extended-release buprenorphine with individuals leaving jail | Drug Use and Addiction Research Programs | April 8, 2021 | $7.3 million |
| A comparative effectiveness trial of sublingual versus extended-release buprenorphine with individuals leaving a carceral setting - abstract although previous research has demonstrated the effectiveness of initiating medications for opioid use disorder (MOUDS) during incarceration, there has been ve | Drug Use and Addiction Research Programs | September 15, 2023 | $3.1 million |
| Treating polysubstance use in methadone maintenance: application of novel digital technology - abstract methadone is a highly effective treatment for opioid use disorder (OUD), but many patients leave treatment prematurely, placing them at high risk of relapse and overdose. Extensive research shows | Drug Use and Addiction Research Programs | September 20, 2022 | $3.0 million |
| Identifying suspected drug overdose deaths in near real-time using data collected by death investigators - this study is part of the nih’s helping to end addiction long-term (HEAL) initiative to speed scientific solutions to the national opioid public health crisis. The NIH heal initiative bolsters | Drug Use and Addiction Research Programs | September 20, 2022 | $2.9 million |
| Optimizing prep implementation and cost-effectiveness among sexual and gender minority individuals with a substance use disorder - abstract in the us most (~70%) annual newly diagnosed HIV infections are among substance-using sexual minority cisgender men (MSM) and gender minority transgender women | Drug Use and Addiction Research Programs | August 26, 2022 | $2.6 million |
| Scope and impact of methadone take-home and telehealth practice changes during the COVID-19 pandemic - abstract methadone is an effective treatment for opioid use disorder (OUD) that is delivered in the U.S. Through specialized opioid treatment programs (OTPS). Since the inception of the otp system | Drug Use and Addiction Research Programs | September 15, 2022 | $2.5 million |
| Comparative- and cost-effectiveness research determining the optimal intervention for advancing transgender women living with HIV to full viral suppression - abstract trans women (TW) achieve suboptimal advancement through the HIV care continuum,1-7 including poor HIV healthcare utilization,8,9 rete | Drug Use and Addiction Research Programs | August 11, 2023 | $2.5 million |
| Opioid use disorder treatment linkage at std clinics using buprenorphine (outlast-b) | Drug Use and Addiction Research Programs | February 9, 2021 | $1.9 million |
| A patient preference trial of sublingual versus extended-release buprenorphine telemedicine and pharmacy linkage for individuals re-entering the community from jail - abstract this proposed study is a patient preference trial (PPT) of xr-b vs. Sl-b in 8 rural jails in Maryland. A total of 500 adults | Drug Use and Addiction Research Programs | September 5, 2025 | $1.4 million |
| Facilitating the implementation of interim methadone to increase treatment access: a multi-site implementation trial | Drug Use and Addiction Research Programs | March 15, 2021 | $1.3 million |
Questions people ask
How much federal grant money does Friends Research Institute, Inc get?
$38.1 million in 23 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Friends Research Institute, Inc the most?
The Department of Health and Human Services, with $38.1 million in 23 awards.
What is Friends Research Institute, Inc's largest federal grant?
$7.3 million under Drug Use and Addiction Research Programs, with its first action in the period on April 8, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Friends Research Institute, Inc?
Its largest are Drug Use and Addiction Research Programs, Research on Healthcare Costs, Quality and Outcomes and Nursing Research.
Other grant recipients in Baltimore
- Maryland Department of Health
- Maryland State Department of Education
- The Johns Hopkins University
- Maryland Department of Human Services
- Maryland Department of Transportation
- Maryland Transit Administration
- Catholic Relief Services - United States Conference of Catholic Bishops
- Maryland Health Benefit Exchange
Largest federal grant recipients in Maryland · Federal grants in Maryland